Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results

Go back to Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 3.85 --0 (-0%)
Previous Close $3.85    52 Week High
Open $3.85    52 Week Low
Day High $3.85    P/E N/A 
Day Low $3.85    EPS
Volume 365